Factors associated with hepatitis C testing, treatment, and current hepatitis C infection among men and women who inject drugs

The Ethos engage study

Datos Bibliográficos

ID14908503
AutoresHeather Valerio (0000-0002-8608-2558, UNSW Sydney, autor de correspondencia), April D Marshall (0000-0001-7476-7894, UNSW Sydney), Anne Conway (0000-0002-9082-9714, UNSW Sydney), Carla Treloar (0000-0002-8230-0386, UNSW Sydney), Lisa Carter, Marianne Martinello (0000-0001-9444-0186, UNSW Sydney), C R Henderson (0000-0001-7264-2676, National Association of People with HIV Australia), Janaki Amin (0000-0003-2161-9366, Macquarie University), Phillip Read (0000-0001-5422-3777, UNSW Sydney), David Silk, D B A Silk (0000-0001-6931-8138, UNSW Sydney), Louisa Degenhardt (0000-0002-8513-2218, UNSW Sydney), Bianca Prain (New South Wales Department of Health), Maryam Alavi (0000-0003-3512-4938, UNSW Sydney), Gregory J Dore (0000-0002-4741-2622, UNSW Sydney), J Grebely (0000-0002-1833-2017, UNSW Sydney)
Año2024
Volumen127
Páginas104394
Fecha de publicación2024-05-01
Peer ReviewedSí
Open AccessSí
TipoARTICLE
RevistaInternational Journal of Drug Policy (JOURNAL)
Identificadores de la revistaISSN: 0955-3959 • E-ISSN: 1873-4758
EditorialElsevier BV (PUBLISHER)
DOI10.1016/j.drugpo.2024.104394
PMID38608357
OpenAlexW4394733879
IdiomaEN
Citas recibidas4
Referencias citadas41

Among 2,395 participants enrolled in ETHOS Engage, 66% (n = 1,591) were men, 33% (n = 786) women, and <1% (n = 18) did not identify as a man or woman. HCV testing history and current infection were similar among men and women. Among men or women ever eligible for HCV treatment (ever chronic HCV) (n = 1,242), women were less likely to report a history of HCV treatment compared to men (227/352, 64% vs. 631/890, 71%; p = 0.03). Among women, those aged <45 were less likely to report HCV testing (aOR: 0.57, 95%CI: 0.36, 0.90), treatment (aOR: 0.47, 95%CI: 0.29, 0.77), and more likely to have HCV infection (aOR: 1.48, 95%CI: 1.00, 2.20) CONCLUSION: Among women, those of childbearing age (<45) were less likely to report testing and treatment and were more likely to have current HCV infection. Women <45 years old should be a priority population for HCV care. Services that interface with these women should be optimised to enhance HCV testing and treatment

Hepatitis C · Hepatitis C virus · Human immunodeficiency virus (HIV · Logistic regression · Men who have sex with men · Viral load · Virus · Hepatitis B Virus Studies · Hepatitis C virus research · HIV, Drug Use, Sexual Risk · Medicine · Immunology · Internal Medicine